CW Advisors LLC Purchases 7,367 Shares of HCA Healthcare, Inc. $HCA

CW Advisors LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 576.9% in the second quarter, Holdings Channel.com reports. The firm owned 8,644 shares of the company’s stock after purchasing an additional 7,367 shares during the quarter. CW Advisors LLC’s holdings in HCA Healthcare were worth $3,312,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in HCA. Saudi Central Bank bought a new stake in HCA Healthcare during the 1st quarter worth approximately $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare in the first quarter worth $27,000. Ameriflex Group Inc. acquired a new position in HCA Healthcare during the 2nd quarter worth about $27,000. Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Finally, Clearstead Trust LLC lifted its stake in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on HCA shares. Barclays boosted their price target on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. The Goldman Sachs Group increased their price target on HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Jefferies Financial Group upped their target price on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $474.53.

HCA Healthcare Stock Performance

Shares of HCA opened at $486.40 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $520.00. The stock has a 50 day moving average price of $459.97 and a two-hundred day moving average price of $410.23. The firm has a market capitalization of $110.99 billion, a P/E ratio of 18.80, a P/E/G ratio of 1.44 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the prior year, the company posted $4.90 earnings per share. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.